What is LymphaTech?
LymphaTech is at the forefront of developing accurate and automated 3D measurement solutions tailored for lymphedema management. Their technology is crucial for physical therapists, oncologists, and manufacturers/fitters of compression garments, enabling precise limb volume and circumference assessments. This innovation significantly enhances the efficiency of clinical care by facilitating frequent self-measurements and streamlining the complex ordering process for compression garments, thereby reducing errors and material waste. LymphaTech's commitment to improving patient care and engagement is supported by extensive clinical research, with their solutions being adopted globally.
How much funding has LymphaTech raised?
LymphaTech has raised a total of $41K across 1 funding round:
Debt
$41K
Debt (2021): $41K with participation from PPP
What's next for LymphaTech?
With the recent influx of substantial expansion capital, LymphaTech is poised for accelerated growth and market expansion. The company's focus on enhancing patient care through precise, automated measurement solutions positions it for increased adoption in both clinical settings and direct-to-consumer markets. Future strategic initiatives will likely involve further technological development, expanding their product offerings, and strengthening partnerships within the healthcare and medical device industries. The significant Series B/C stage funding indicates a strong investor confidence in LymphaTech's business model and its potential to capture a larger share of the lymphedema management market.
See full LymphaTech company page
